Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/1995
06/29/1995WO1995017185A1 A method of treating gastrointestinal motility disorders
06/29/1995WO1995017180A1 A method of treating gastrointestinal motility disorders
06/29/1995WO1995014085A3 A method for detection of alterations in the dna mismatch repair pathway
06/29/1995CA2179492A1 A method of treating gastrointestinal motility disorders
06/29/1995CA2179491A1 A method of treating gastrointestinal motility disorders
06/29/1995CA2178811A1 Anti-hepatitis b viral oligonucleotides
06/29/1995CA2178094A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
06/28/1995EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them
06/28/1995EP0659737A2 Catecholamine surrogates useful as B3 agonists
06/28/1995EP0659401A1 Semi-paste oral preparations comprising povidone-iodine, potassium iodide and a sugar alcohol
06/28/1995EP0659183A1 Heteroaryl compounds used as pharmaceuticals
06/28/1995CN1104106A capsule preparation for curing pile
06/27/1995US5428182 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
06/27/1995US5428019 Bombesin analogs
06/27/1995US5428018 Phenylalanine analogs of bombesin
06/27/1995US5427769 Contacting teeth with food containing milk isolated micellar casein to inhibit oral streptococcus sobrinus growth
06/27/1995CA2022956C Agglomerated psyllium husk containing edible acid
06/27/1995CA1336099C Urea based lipoxygenase compounds
06/22/1995WO1995016706A1 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
06/22/1995WO1995016702A1 Peptide inhibitors of cxc intercrine molecules
06/22/1995WO1995016685A1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
06/22/1995WO1995016683A1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995WO1995016679A1 Morpholine and thiomorpholine tachykinin receptor antagonists
06/22/1995WO1995016663A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995WO1995016449A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995WO1995016446A1 Ranitidine compositions
06/22/1995WO1995016442A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995DE4444606A1 Sennoside A and B prodn.
06/22/1995CA2179203A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995CA2179068A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995CA2179006A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138457A1 Non-peptide tachykinin receptor antagonists
06/21/1995EP0658539A1 Excitatory amino acid receptor antagonists
06/21/1995EP0658161A1 Substituted thiazolidinedione derivatives
06/21/1995EP0658157A1 Diaryl piperazinoacetamide compounds as antimuscarinic agents
06/21/1995EP0658106A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass
06/20/1995US5426226 Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
06/20/1995US5426107 Pyrazolopyrimidinone antianginal agents
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995US5425953 Sustained release film forming liquid containing water soluble cellulosic polymer, peroxy compound, soluble stabilizer, vehicle; storage stability
06/20/1995US5425950 Antiserotonine agent
06/15/1995WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015951A1 Novel imidazole derivative and process for producing the same
06/15/1995WO1995015950A1 Compounds
06/15/1995WO1995015948A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995WO1995015752A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
06/15/1995WO1995013297A3 Improved immunogenic compositions against human gastrin 17
06/15/1995CA2178634A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995CA2177739A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657428A1 Preparation of 3,4,4-trisubstitutedpiperidinyl-n-alkylcarboxylates and intermediates, useful as opioid antagonists
06/14/1995EP0657426A2 Tricyclic pyrrole derivatives
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656788A1 Hla binding peptides and their uses
06/14/1995EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
06/14/1995CN1103584A Sanzhu oral liquid and its preparing method
06/13/1995US5424328 Treatment of central nervous system disorders
06/13/1995US5424292 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
06/13/1995US5424064 Treatment of reflux esophagitis using dimethylpolysiloxane
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015170A1 Use of dimeticone for treating constipation
06/08/1995WO1995015169A1 Use of dimeticone for treating aphthae and stomatitis
06/08/1995WO1995015159A1 Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177966A1 Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/07/1995EP0656354A1 Substituted N-piperidino 3-pyrazolecarboxamide
06/07/1995EP0656345A1 Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases
06/07/1995EP0656208A2 Use of synthetic huminates for the manufacture of a medicament for the treatment of disease of the mucosa
06/06/1995US5422424 Antibiotic cryptdin peptides and methods of their use
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422358 Muscarinic receptor antagonists
06/06/1995US5422354 Quinuclidine derivatives
06/06/1995US5422342 A hydrolase inhibitor comprising a protected oligopeptides for treating fibrose of lungs, liver and skins, atherosclerosis
06/06/1995US5422124 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
06/06/1995CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
06/04/1995CA2137028A1 Pharmaceutical compounds
06/04/1995CA2136904A1 Excitatory amino acid receptor antagonists
06/01/1995WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
06/01/1995WO1995014691A1 NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
06/01/1995WO1995014483A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex
06/01/1995WO1995014436A1 A retrograde high frequency tissue splitter
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
05/1995
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655440A2 1-Aminoethylindoles
05/31/1995EP0655252A1 Agent for suppressing the motor activity of gastrointestinal tracts
05/31/1995EP0655249A1 Moenomycin as a medicament for the treatment of stomach ulcer
05/31/1995EP0655248A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
1 ... 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 ... 1258